Gefitinib is of more benefit in chemotherapy-naive patients with good performance status and adenocarcinoma histology : Retrospective analysis of 575 Korean patientsDAE HO LEE; HAN, Ji-Youn; HEUNG TAE KIM et al.Lung cancer. 2006, Vol 53, Num 3, pp 339-345, issn 0169-5002, 7 p.Article

The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancerHAN, Ji-Youn; BYUNG GIL CHOI; JI YOUNG CHOI et al.Lung cancer. 2006, Vol 54, Num 2, pp 227-234, issn 0169-5002, 8 p.Article

9-cis-retinoic acid Treatment increases serum concentrations of α-tocopherol in former smokersHAN, Ji-Youn; LIU, Diane D; LEE, J. Jack et al.Clinical cancer research. 2005, Vol 11, Num 6, pp 2305-2311, issn 1078-0432, 7 p.Article

Association of p53 Codon 72 Polymorphism and MDM2 SNP309 With Clinical Outcome of Advanced Nonsmall Cell Lung CancerHAN, Ji-Youn; GEON KOOK LEE; DAE HO JANG et al.Cancer. 2008, Vol 113, Num 4, pp 799-807, issn 0008-543X, 9 p.Article

Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancerHAN, Ji-Youn; LIM, Hyeong-Seok; YONG HOON PARK et al.Lung cancer. 2009, Vol 63, Num 1, pp 115-120, issn 0169-5002, 6 p.Article

Immunohistochemical expression of integrins and extracellular matrix proteins in non-small cell lung cancer: correlation with lymph node metastasisHAN, Ji-Youn; HONG SUG KIM; SUG HYUNG LEE et al.Lung cancer. 2003, Vol 41, Num 1, pp 65-70, issn 0169-5002, 6 p.Article

Ventriculolumbar Perfusion Chemotherapy for the Treatment of Leptomeningeal Carcinomatosis: A Phase I Study With Pharmacokinetic DataGWAK, Ho-Shin; LIM, Hyeong-Seok; SHIRT, Sang-Hoon et al.American journal of clinical oncology. 2013, Vol 36, Num 5, pp 491-499, issn 0277-3732, 9 p.Article

Randomized phase II study of two opposite administration sequences of irinotecan and cisplatin in patients with advanced nonsmall cell lung carcinomaHAN, Ji-Youn; LIM, Hyeong-Seok; DAE HO LEE et al.Cancer. 2006, Vol 106, Num 4, pp 873-880, issn 0008-543X, 8 p.Article

Gefitinib as a first-linetherapy of advanced or metastatic adenocarcinoma of the lung in never-smokersDAE HO LEE; HAN, Ji-Youn; HONG GI LEE et al.Clinical cancer research. 2005, Vol 11, Num 8, pp 3032-3037, issn 1078-0432, 6 p.Article

A Phase II study of weekly docetaxel plus capecitabine for patients with advanced nonsmall cell lung carcinomaHAN, Ji-Youn; DAE HO LEE; HAE YOUNG KIM et al.Cancer. 2003, Vol 98, Num 9, pp 1918-1924, issn 0008-543X, 7 p.Article

A phase II study of sunitinib in patients with relapsed or refractory small cell lung cancerHAN, Ji-Youn; HYAE YOUNG KIM; KUN YOUNG LIM et al.Lung cancer. 2013, Vol 79, Num 2, pp 137-142, issn 0169-5002, 6 p.Article

Primary Chemotherapy for Newly Diagnosed Nonsmall Cell Lung Cancer Patients With Synchronous Brain Metastases Compared With Whole-Brain Radiotherapy Administered First : Result of a Randomized Pilot StudyDAE HO LEE; HAN, Ji-Youn; HEUNG TAE KIM et al.Cancer. 2008, Vol 113, Num 1, pp 143-149, issn 0008-543X, 7 p.Article

Randomized Phase 2 Study of Irinotecan Plus Cisplatin Versus Gemcitabine Plus Vinorelbine as First-line Chemotherapy With Second-line Crossover in Patients With Advanced Nonsmall Cell Lung CancerHAN, Ji-Youn; DAE HO LEE; JUNG EUN SONG et al.Cancer. 2008, Vol 113, Num 2, pp 388-395, issn 0008-543X, 8 p.Article

A phase II study of irinotecan plus cisplatin for patients with advanced stage IIIB or IV NSCLC previously treated with nonplatinum-based chemotherapyKIM, Heung T; HAN, Ji-Youn; LEE, Dae H et al.Cancer. 2006, Vol 107, Num 4, pp 799-805, issn 0008-543X, 7 p.Article

Phase II study of weekly irinotecan plus capecitabine for chemotherapy-naive patients with advanced nonsmall cell lung carcinomaHAN, Ji-Youn; DAE HO LEE; SUNG YOUNG LEE et al.Cancer. 2005, Vol 104, Num 12, pp 2759-2765, issn 0008-543X, 7 p.Article

A phase II trial of modified weekly irinotecan and cisplatin for chemotherapy-naive patients with metastatic or recurrent squamous cell carcinoma of the esophagusDAE HO LEE; HEUNG TAE KIM; HAN, Ji-Youn et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 1, pp 83-88, issn 0344-5704, 6 p.Article

Influence of the organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancerHAN, Ji-Youn; LIM, Hyeong-Seok; EUN SOON SHIN et al.Lung cancer. 2008, Vol 59, Num 1, pp 69-75, issn 0169-5002, 7 p.Article

Randomized Phase 2 Study of Subcutaneous Amifostine Versus Epoetin-α Given 3 Times Weekly During Concurrent Chemotherapy and Hyperfractionated Radiotherapy for Limited-disease Small Cell Lung CancerHAN, Hye-Suk; HAN, Ji-Youn; SUN YOUNG YU et al.Cancer. 2008, Vol 113, Num 7, pp 1623-1631, issn 0008-543X, 9 p.Article

A phase II study of Weekly Irinotecan and capecitabine in patients with previously treated non-small cell lung cancerHAN, Ji-Youn; DAE HO LEE; HYAE YOUNG KIM et al.Clinical cancer research. 2003, Vol 9, Num 16, pp 5909-5914, issn 1078-0432, 6 p., 1Article

First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the LungHAN, Ji-Youn; PARK, Keunchil; LEE, Jung-Shin et al.Journal of clinical oncology. 2012, Vol 30, Num 10, pp 1122-1128, issn 0732-183X, 7 p.Article

Circulating Cell-Free DNA in Plasma of Never Smokers with Advanced Lung Adenocarcinoma Receiving Gefitinib or Standard Chemotherapy as First-Line TherapyYOUNG JOO LEE; YOON, Kyong-Ah; HAN, Ji-Youn et al.Clinical cancer research (Print). 2011, Vol 17, Num 15, pp 5179-5187, issn 1078-0432, 9 p.Article

Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with lrinotecan -pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancerHAN, Ji-Youn; LIM, Hyeong-Seok; YOO, Yeon-Kyeong et al.Cancer. 2007, Vol 110, Num 1, pp 138-147, issn 0008-543X, 10 p.Article

Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatinHAN, Ji-Youn; LIM, Hyeong-Seok; EUN SOON SHIN et al.Journal of clinical oncology. 2006, Vol 24, Num 15, pp 2237-2244, issn 0732-183X, 8 p.Article

Effects of 9-cis-retinoic acid on the insulin-like growth factor axis in former smokersLEE, Ho-Young; YOON SOO CHANG; HAN, Ji-Youn et al.Journal of clinical oncology. 2005, Vol 23, Num 19, pp 4439-4449, issn 0732-183X, 11 p.Article

Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancersSHIN, Min Sun; KIM, Hong Sug; HAN, Ji Youn et al.Cancer research (Baltimore). 2001, Vol 61, Num 13, pp 4942-4946, issn 0008-5472Article